Bone Marrow Transplant Treats Mitochondrial Heart and Brain Damage

A new study led by Stanford Medicine reveals that bone marrow transplants can repair damage in the heart and brain. This finding offers a potential treatment for mitochondrial disorders, a group of genetic diseases where cells lose the ability to generate energy efficiently.

The research, published in Nature Communications, focused on Friedreich's ataxia, a condition that affects coordination and heart function. In mouse models, transplanted immune cells traveled to damaged tissues and donated healthy mitochondria to neighboring cells, partially reversing disease symptoms.

Cells exchange power sources via blood

Mitochondria are the engines of the cell, converting glucose into ATP, the energy currency of life. When these engines fail, energy-heavy organs like the brain and heart suffer the most. The study demonstrated that healthy immune cells from a donor can act as mobile support units, delivering functional mitochondria to struggling cells.

Natalia Gomez-Ospina, the senior author, noted that this process leverages the circulatory system to treat non-blood organs. This mechanism suggests that cells communicate and share resources in ways previously underestimated, providing a new avenue for treating conditions that currently lack effective therapies.

Current treatments face significant barriers

Mitochondrial diseases affect approximately one in 5,000 people and often lead to severe degeneration. Current standard care involves high doses of antioxidants to reduce damage, but this approach does not fix the underlying genetic defects. The condition is particularly challenging because mutations can occur in either nuclear or mitochondrial DNA, complicating targeted interventions.

Gene therapy trials are underway, but they face major hurdles. Because the mutations are diverse, therapies must be developed individually. Additionally, delivering corrected genes to deep tissues like the brain is difficult due to the blood-brain barrier. Viral vectors, often used for delivery, struggle to distribute evenly throughout the body, limiting their effectiveness.

Marrow transplant offers a novel route

The team tested this concept in mice with Friedreich's ataxia, a disease that causes neurodegeneration and heart failure. By using a modified bone marrow transplant, they allowed donor stem cells to generate new immune cells. These cells then migrated to affected tissues, offering a systemic approach that bypasses the delivery challenges associated with direct gene editing.

While this method shows promise, it is not without trade-offs. Bone marrow transplants are complex procedures typically reserved for blood cancers, carrying risks of immune rejection and infection. However, as reported by Medical Xpress, this unexpected benefit suggests that the blood system itself can be a vehicle for delivering cellular repairs to vital organs.